0001009448-20-000004.txt : 20200713 0001009448-20-000004.hdr.sgml : 20200713 20200713161822 ACCESSION NUMBER: 0001009448-20-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200713 DATE AS OF CHANGE: 20200713 EFFECTIVENESS DATE: 20200713 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sapience Therapeutics, Inc. CENTRAL INDEX KEY: 0001661731 IRS NUMBER: 475419141 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-370845 FILM NUMBER: 201025407 BUSINESS ADDRESS: STREET 1: 500 MAMARONECK AVENUE STREET 2: SUITE 320 CITY: HARRISON STATE: NY ZIP: 10528 BUSINESS PHONE: (914) 607-6931 MAIL ADDRESS: STREET 1: 500 MAMARONECK AVENUE STREET 2: SUITE 320 CITY: HARRISON STATE: NY ZIP: 10528 D 1 primary_doc.xml X0708 D LIVE 0001661731 Sapience Therapeutics, Inc. 500 MAMARONECK AVENUE SUITE 320 HARRISON NY NEW YORK 10528 (914) 607-6931 DELAWARE None None Corporation true 2015 Barry Kappel 500 Mamaroneck Avenue Suite 320 Harrison NY NEW YORK 10528 Executive Officer Director Howard Pien 500 Mamaroneck Avenue Suite 320 Harrison NY NEW YORK 10528 Director David Scheinberg 500 Mamaroneck Avenue Suite 320 Harrison NY NEW YORK 10528 Director Robert Ruffolo 500 Mamaroneck Avenue Suite 320 Harrison NY NEW YORK 10528 Director Christian Schade 500 Mamaroneck Avenue Suite 320 Harrison NY NEW YORK 10528 Director Biotechnology Decline to Disclose 06b false 2020-06-29 false true false 50000 Maxim Group LLC 12078 None None 405 Lexington Ave New York NY NEW YORK 10174 All States false 30000000 8010876 21989124 false 83 701087 0 0 false Sapience Therapeutics, Inc. /s/ Barry Kappel Barry Kappel President and CEO 2020-07-13